ENTRY       D09215                      Drug
NAME        Eslicarbazepine (USAN/INN)
FORMULA     C15H14N2O2
EXACT_MASS  254.1055
MOL_WEIGHT  254.2839
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02034  Carboxamide antiepileptic
            Metabolizing enzyme inhibitor
             DG01933  CYP2C19 inhibitor
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
REMARK      ATC code: N03AF04
            Chemical structure group: DG00848
            Product (DG00848): D09612<US>
EFFICACY    Anticonvulsant, Antiepileptic
COMMENT     Carboxamide derivative
            Active metabolite of oxcarbazepine [DR:D00533]
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04728(6323)  Dopaminergic synapse
INTERACTION CYP inhibition: CYP2C19 [HSA:1557]
            CYP induction: CYP3A4 [HSA:1576]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AF Carboxamide derivatives
                 N03AF04 Eslicarbazepine
                  D09215  Eslicarbazepine (USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02034  Carboxamide antiepileptic
                DG00848  Eslicarbazepine
                 D09215  Eslicarbazepine
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               DG00848  Eslicarbazepine
                D09215  Eslicarbazepine
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00848  Eslicarbazepine
                 D09215  Eslicarbazepine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN2A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN3A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN4A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN5A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN8A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN9A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN10A
                 D09215  Eslicarbazepine (USAN/INN)
                SCN11A
                 D09215  Eslicarbazepine (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09215
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02034  Carboxamide antiepileptic
                DG00848  Eslicarbazepine
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               DG00848  Eslicarbazepine
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00848  Eslicarbazepine
DBLINKS     CAS: 104746-04-5
            PubChem: 96025895
            ChEBI: 174358
            LigandBox: D09215
ATOM        19
            1   C8y C    26.3200  -20.6500
            2   N1y N    27.5800  -20.0200
            3   C8y C    28.8400  -20.6500
            4   C8y C    29.1200  -21.9800
            5   C8y C    26.0400  -22.0500
            6   C1x C    28.2800  -23.1000
            7   C1y C    26.8800  -23.1000
            8   C8x C    25.2700  -19.6700
            9   C8x C    23.9400  -20.1600
            10  C8x C    23.6600  -21.4900
            11  C8x C    24.7100  -22.4700
            12  C8x C    30.5200  -22.3300
            13  C8x C    31.5000  -21.3500
            14  C8x C    31.1500  -20.0200
            15  C8x C    29.7500  -19.6000
            16  C5a C    27.5800  -18.6200
            17  O5a O    26.3900  -17.9200
            18  N1a N    28.7700  -17.9200
            19  O1a O    26.2500  -24.3600
BOND        21
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     1   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    5  11 2
            13    4  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17   15   3 2
            18    2  16 1
            19   16  17 2
            20   16  18 1
            21    7  19 1 #Down
///
